United States · FDA National Drug Code directory

Olanzapine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0093-5247_379692bf-82b3-48f3-8d1f-5a27949ce441
Product NDC: 0093-5247
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: Olanzapine
Labeler: Teva Pharmaceuticals USA, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20120124
Source listing expiry: 20271231

Source-listed ingredients

OLANZAPINE — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 BLISTER PACK in 1 CARTON (0093-5247-65) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-5247-19) · 0093-5247-65

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →